Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

275 Views

Z4. COVID-19 Treatment

Poster Session: COVID-19: Treatment

(P-2031) Thorough QT/QTc Clinical Study to Evaluate the Effect of Remdesivir on Cardiac Repolarization in Healthy Participants

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Co-Author(s)

OA

Olena Anoshchenko, PhD

Clinical Pharmacologist
Gilead Sciences, Inc.
Foster City, California, United States

Presenting Author(s)

Mazin Abdelghany, MD

Director, Clinical Development
Gilead Sciences, Inc.
Foster City, California, United States

Co-Author(s)

RH

Robert H. Hyland, DPhil

Gilead Sciences, Inc.
Foster City, California, United States
SD

Santosh Davies, MD

Gilead Sciences, Inc.
Foster City, California, United States
AK

Anna Kwan, BS

Gilead Sciences, Inc.
Foster City, California, United States
RD

Ran Duan, PhD

Gilead Sciences, Inc.
Foster City, California, United States
AK

Aryun Kim, PharmD

Principal Scientist
Gilead Sciences, Inc.
Foster City, California, United States